Clinical Trials in Maryland

Showing 14461-14480 of 23,284 trials

Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia

NCT00492336

This is a study of a new medication for the treatment of cognitive impairments (thinking difficulties) and negative symptoms in people with schizophrenia. The new medication is rasagiline. Rasagiline is a drug which has been approved by the Food and Drug Administration for the treatment of Parkinson's disease. It is used to treat cognitive problems.

Schizophrenia

University of Maryland, Baltimore84 participantsStarted Jan 2007

Baltimore, Maryland, United States • Catonsville, Maryland, United States • Catonsville, Maryland, United States +2 more locations

COMPLETEDPhase 315 miles

A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

NCT01168973

The purpose of the study is to compare the survival of participants who receive chemotherapy and ramucirumab versus chemotherapy alone as second line treatment for NSCLC after prior first line platinum-based chemotherapy.

Non-Small Cell Lung Cancer

Eli Lilly and Company1,253 participantsStarted Dec 2010

Phoenix, Arizona, United States • Sedona, Arizona, United States • Fayetteville, Arkansas, United States +228 more locations

Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia

A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

Find Trials by Condition in Maryland

ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

A Study in Second Line Metastatic Colorectal Cancer

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Riociguat in Scleroderma Associated Digital Ulcers

A Study in Participants With Moderate to Severe Psoriasis

Breathe With Ease: A Unique Approach to Managing Stress (BEAMS)

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

Study of Ramucirumab in Ovarian Cancer

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Tailored Mindfulness Intervention in Adolescence

MRI to Detect Breast Tumors in Women

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease

Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women

A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses